Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:509730.
doi: 10.1155/2012/509730. Epub 2011 Nov 23.

L-carnitine improves the asthma control in children with moderate persistent asthma

Mohammed Al-Biltagi  1 , Mona Isa, Adel Salah Bediwy, Nevien Helaly, Dalia D El Lebedy
Affiliations

L-carnitine improves the asthma control in children with moderate persistent asthma

Mohammed Al-Biltagi et al. J Allergy (Cairo). 2012.

Abstract

The objective. was to investigate L-Carnitine level and the effects of its supplementation in children with moderate persistent Asthma. Methods. Free and total serum carnitine levels were measured in 50 children having moderate persistent asthma and 50 healthy control children. The patients group was randomly divided into two subgroups. Subgroup A was supplemented with L-carnitine for 6 months while subgroup B was used as a placebo controls. Both subgroups were assessed by pulmonary function tests (PFT) and childhood-asthma control test (C-ACT) before and 6 months after carnitine supplementation. Results. Total and free carnitine levels were significantly lower in patient group than in control group. PFT and C-ACT showed significant improvements in asthmatic children supplemented with L-carnitine than in those who were not supplemented. Conclusion. L-carnitine levels were initially lower in moderate persistent asthmatic children as compared to healthy control children. Asthmatic children who received L-carnitine supplementation showed statistically significant improvement of C-ACT and PFT.

PubMed Disclaimer

References

    1. National Institute of Health. Expert panel report 3: guidlines for diagnosis and management of asthma. Washington, DC, USA, NIH, 2007, http://www.nhlbi.nih.gov/guidelines/asthma.
    1. Antonicelli L, Bucca C, Neri M, et al. Asthma severity and medical resource utilisation. European Respiratory Journal. 2004;23(5):723–729. - PubMed
    1. Busse WW, Banks-Schlegel S, Wenzel SE. Pathophysiology of severe asthma. Journal of Allergy and Clinical Immunology. 2000;106(6):1033–1042. - PubMed
    1. Miller MK, Johnson C, Miller DP, Deniz Y, Bleecker ER, Wenzel SE. Severity assessment in asthma: an evolving concept. Journal of Allergy and Clinical Immunology. 2005;116(5):990–995. - PubMed
    1. Biltagi MA, Baset AA, Bassiouny M, Kasrawi MA, Attia M. Omega-3 fatty acids, vitamin C and Zn supplementation in asthmatic children: a randomized self-controlled study. Acta Paediatrica, International Journal of Paediatrics. 2009;98(4):737–742. - PubMed

LinkOut - more resources